Viewing nowBidreba Sustained Release Tablet 150mg (Levamisole)
Rebamipide 150mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

MFDS item code 202008940 · Approved 2020.12.16 · Insurance code 671807220
Treatment of acute gastritis and chronic gastritis exacerbation through improvement of gastric mucosal lesions (erosion, bleeding, etc.)
This medication is used to improve gastric mucosal lesions such as erosion, bleeding, redness, and swelling that occur during acute exacerbation of acute gastritis and chronic gastritis.
Adults should take 1 tablet twice a day, once in the morning and once in the evening. This medication should be swallowed whole and should not be divided or chewed.
This medication should not be used by individuals who are allergic to any component of this medication or have a history of hypersensitivity. Additionally, this medication contains lactose, so those with lactose intolerance or specific genetic lactose metabolism disorders should not take it. During the usage of this medication, gastrointestinal disturbances, infections, muscle pain, dizziness, and other side effects may occur; if there are any unusual symptoms, consult a doctor immediately. Rarely, serious allergic reactions or blood abnormalities and liver function impairment may occur, so the physical condition should be closely monitored. Women who are pregnant or may become pregnant should use this medication with caution, and breastfeeding mothers should avoid nursing while taking this medication. The safety for children or adolescents has not been adequately confirmed, so caution is required in their usage. Elderly individuals may have decreased bodily function and should pay special attention to gastrointestinal-related side effects. This medication should be kept out of reach of children and should not be transferred to another container for safety.
Hives, severe swelling (edema), chest tightness, difficulty breathing, cold sweat, pallor, severe rash with high fever, blisters, skin peeling, pain in mouth/eyes mucosa, difficulty breathing or shortness of breath, asthma attacks, respiratory distress accompanied by cough and fever, yellowing of skin or eyes (jaundice), extreme lethargy, sudden and severe headache, thunderclap headache, seizures, confusion of consciousness, visual disturbances, paralysis, urination
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air and moisture, so it should be stored in a tightly sealed container. It is recommended to maintain the storage temperature between 1 degree and 30 degrees Celsius at room temperature.
White round sustained release tablet
30 tablets/bottle, 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowRebamipide 150mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Rebamipide 100mg
Tablet · Prescription medication
Korea Otsuka Pharmaceutical Co., Ltd.

Rebamipide 100mg
Tablet · Prescription medication
Kyungdong Pharmaceutical Co., Ltd.

Rebamipide 100mg
Tablet · Prescription medication
Sinphong Pharmaceutical Co., Ltd.

Rebamipide 100mg
Tablet · Prescription medication
Yuhan Corporation

Rebamipide 100mg
Tablet · Prescription medication
Jongkundang Corporation

Rebamipide 100mg
Tablet · Prescription medication
Donghwa Pharmaceutical Co., Ltd.

Rebamipide 100mg
Tablet · Prescription medication
Sama Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.